Introduction {#Sec1}
============

Nuclear factor of activated T cells (NFAT) and nuclear factor κB (NFκB) are Ca^2+^-dependent and PKCθ-dependent transcription factors that mediate the immune response in T lymphocytes (T cells).[@CR8],[@CR16],[@CR25],[@CR44],[@CR49] In resting cells both NFAT and NFκB reside primarily in the cytoplasm, NFAT in its phosphorylated form and NFκB bound to the inhibitor IκB. T cell receptor stimulation initiates a cascade of intracellular reactions causing an increase in the cytosolic calcium concentration and a resulting translocation of both NFAT and NFκB to the nucleus.[@CR19],[@CR48] Both NFAT and NFκB may bind to promoter regions of DNA and, in concert with other transcription factors, allow expression of genes responsible for the production of the interleukins IL-2 by NFAT[@CR50] and IL-8 by NFκB.[@CR58]

In the NFAT pathway (Fig. [1](#Fig1){ref-type="fig"}a), Ca^2+^ activates the phosphatase calcineurin, which binds to and dephosphorylates NFAT.[@CR34],[@CR45],[@CR59] Dephosphorylation exposes nuclear localization signals,[@CR10] resulting in rapid translocation of the NFAT-calcineurin complex to the nucleus where it can participate in promoting gene transcription.[@CR51] The cytoplasm-to-nucleus translocation is opposed by kinases such as GSK-3 and possibly protein kinase A that block the Ca^2+^-calcineurin dephosphorylation of NFAT in the cytoplasm, or that rephosphorylate free NFAT in the nucleus.[@CR9],[@CR43] Association of NFAT with activated calcineurin inhibits the kinase activity; in the absence of activated calcineurin, dephosphorylated NFAT in the nucleus is rephosphorylated and exported. This futile shuttling of NFAT into and out of the nucleus results in little gene transcription, thus gene expression activated by NFAT requires continuously active calcineurin.[@CR54],[@CR62]

![(a) Schematic diagram of the mechanism of action of NFAT. At rest, NFAT is in its phosphorylated form (NFAT:P~i~) and located mainly in the cytosol. Upon activation, a rise in \[Ca\]~i~ activates calcineurin (C) which binds NFAT:P~i~ and dephosphorylates it, allowing its import into the nucleus where it can act on the DNA. (b) Schematic diagram of the mechanism of action of NFκB. At rest, NFκB is bound to its inhibitor IκB mainly in the cytosol (NFκB:IκB). Activation of calcineurin (C) synergizes with PKCα activating an early phase of the kinase IKK and activation of PKCθ activates a later phase of IKK which phosphorylates IκB. It then dissociates from NFκB allowing NFκB to be imported into the nucleus where it can act on the DNA.](10439_2006_9179_Fig1_HTML){#Fig1}

In contrast to NFAT, NFκB is retained in the cytoplasm (Fig. [1](#Fig1){ref-type="fig"}b) not by phosphorylation but by association with the inhibitory IκB proteins.[@CR7] In resting cells, NFκB and IκB can dissociate in the cytoplasm and translocate to the nucleus.[@CR14] Reassociation of NFκB and IκB masks nuclear localization signals on both species resulting in nuclear export. NFκB has little opportunity to bind to DNA during this shuttling and so little transcription occurs. Stimulation of the T cell receptor, however, initiates a cascade of reactions proceeding through Ca^2+^[@CR48] and PKCθ[@CR33],[@CR56] that results in activation of the IκB kinase IKK. IKK phosphorylates IκB associated with NFκB, allowing the IκB to dissociate from NFκB and marking the IκB for subsequent polyubiquitination and degradation by the proteasome.[@CR20],[@CR36] NFκB is freed by this degradation, nuclear localization signals on NFκB are exposed, and it is translocated to the nucleus where it can bind to DNA and promote gene transcription. IκB is resynthesized when the calcium and PKCθ concentration decrease. Newly formed IκB translocates to the nucleus where it binds to NFκB and masks its nuclear localization signals. The NFκB:IκB complex is then exported to the cytoplasm thus completing the activation-deactivation cycle. Recently, Hoffman and co-workers showed that oscillations in the IκB concentration are observed experimentally and modeled its mechanism.[@CR26]

In many cells, interplay of the sources and sinks of Ca^2+^ results in oscillations in the intracellular calcium concentration when surface receptors are stimulated by agonist.[@CR11] In particular, T cells display calcium oscillations in response to T cell receptor activation.[@CR21] The transcription factors NFAT and NFκB respond in different ways to the frequency of these oscillations, thus differentiating the activation of NFAT and NFκB. In this way differential transcription factor activation and consequent gene expression is conferred through a ubiquitous second messenger, namely Ca^2+^.[@CR22] Calcium oscillations have also been shown to increase the level of NFAT activation at low levels of stimulation over a steady rise in Ca^2+^, increasing the efficiency of low-level signal detection.[@CR22] Furthermore, overexpression of calcineurin partially replaces the calcium requirement for NFAT activation, as does the expression of constitutively active calcineurin.[@CR39],[@CR15]

Defects in the activation of NFAT and NFκB and expression of IL-2 and IL-8, respectively, have been implicated in a number of human diseases and conditions. In several patients, failure to activate NFAT was shown to cause severe combined immunodeficiency disease, SCID.[@CR23] Overexpression of IL-8 can cause psoriasis and rheumatoid arthritis.[@CR58] Other conditions related to defects in NFAT and NFκB activation include asthma, allergy, inflammation, and septic shock.

These pathways also contain an important target for drugs such as cyclosporin A and FK506, which act as powerful immunosuppressants by blocking the activation of calcineurin's phosphatase activity,[@CR15],[@CR18],[@CR39] thereby suppressing activation of NFAT and NFκB in T cells. Furthermore, the PKCθ inhibitor rottlerin can block PKCθ translocation to the immunological synapse (IS),[@CR57] which suppresses the activation of NFκB in T cells. These properties make these drugs useful not only in combating immune system diseases but also in preventing the rejection of transplanted tissues. But the general immune system suppression that results with cyclosporin A and FK506 leads to severe side effects, such as secondary tumors and opportunistic infections,[@CR30] and progressive loss of renal function and neurotoxicity.[@CR5] Additionally, inhibition of transcription factor activation in other types of cells can have unintended and undesirable consequences.[@CR1]

To understand better how signal transduction pathways function, to help find therapies and cures for immune system diseases, and to find better ways to control the immune system in transplant patients it would be useful to understand the NFAT and NFκB pathways in a quantitative fashion.

Models and Mechanisms {#Sec2}
=====================

We have developed mathematical models for the action of NFAT and NFκB that simulate the activation and deactivation of each factor by changes in intracellular calcium concentration. Two separate models have been developed, one for NFAT and one for NFκB. We required both models to incorporate experimentally determined reaction pathways and to simulate activation and deactivation of the transcription factors through experimentally determined intermediates and over physiological calcium concentrations. Both models use parameters derived, as much as possible, from experimental observations (Tables [1](#Tab1){ref-type="table"}--[4](#Tab4){ref-type="table"}). We required the models to be capable of simulating the system response to calcium concentration oscillations and, in line with experimental observations,[@CR22] to show a different response in the activation of NFAT and NFκB to changes in the frequency of the oscillations. We expect the NFAT model to show that oscillations in the concentration of calcium enhance the activity of NFAT at low calcium concentrations and that overexpression of calcineurin replaces the requirement for calcium in the activation of NFAT. For both the NFAT and NFκB models we expect the models to require sustained calcium signaling for gene expression.TABLE 1.NFAT rate constants.Rate constantValueSource*k*~1~0.0000256 s^−1^Estimate*k*~2~0.00256 s^−1^Loh et al.[@CR34]*k*~3~0.005 s^−1^Estimate*k*~4~0.5 s^−1^Estimate*k*~5~0.0019 s^−1^Shibasaki et al.[@CR52]*k*~6~0.00092 s^−1^Shibasaki et al.[@CR52]*k*~7~0.005 s^−1^Estimate*k*~8~0.5 s^−1^Estimate*k*~9~0.5 s^−1^Estimate*k*~10~0.005 s^−1^Estimate*k*~11~6.63 μM^−1^ s^−1^Adjusted to control rate of activation observed by Shaw et al.[@CR51]*k*~12~0.00168 s^−1^Adjusted to control rate of deactivation observed by Beals et al. [@CR10]*k*~13~0.5 s^−1^to agree with similar reactions given by Klee et al.[@CR32]*k*~14~0.00256 s^−1^Loh et al.[@CR34]*k*~15~0.00168 s^−1^Adjusted to control rate of deactivation observed by Beals et al.[@CR10]*k*~16~6.63μM^−1^s^−1^Adjusted to control rate of activation observed by Shaw et al.[@CR51]*k*~17~0.0015 s^−1^Zhu and McKeon[@CR62]*k*~18~0.00096 s^−1^Zhu and McKeon[@CR62]*k*~19~1.0μM^−3^s^−1^Klee et al.[@CR32]; Kakalis et al.[@CR29]*k*~20~1.0 s^−1^Klee et al.[@CR32], Kakalis et al.[@CR29]*k*~21~0.21 s^−1^Estimate and adjusted relative to *k*~22~ to give equal calcium ion concentrations in nucleus and cytoplasm*k*~22~0.5 s^−1^EstimateTABLE 2.Concentration and volume parameters.ParameterValueSourceCell diameter9000 nMEstimate (Alberts et al.[@CR2])Nucleus diameter6000 nMEstimate (Alberts et al.[@CR2])Nucleus volume (v~n~)113 μm^3^CalculatedCytosol volume (v~c~)269 μm^3^CalculatedResting cell \[Ca^2+^\]100 nMAlberts et al.[@CR2]Activated cell \[Ca^2+^\]1000 nMAlberts et al.[@CR2]Total calcineurin concentration60.0 nMCrabtree[@CR17]Total NFκB concentration52.9 nMCarlotti et al.[@CR13]Total NFAT concentration7.23 nMEstimateTotal IκB concentration55.0 nMCarlotti et al.[@CR13]Number calcium ions required to activate each calcineurin molecule3Kakalis et al.[@CR29]Total PKCθ concentration2000 nMEstimateTotal PKCα concentration1000 nMEstimateTABLE 3.PKCα membrane-binding parameters.ParameterDefinitionValueSource*K*~Ca~Dissociation constant22.0 μMNalefski et al.[@CR38]*h*Calcium binding cooperativity1.5Nalefski et al.[@CR38]*n*Stoichiometric coefficient2 mol/molNalefski et al.[@CR38]*K*~DAG~Dissociation constant10.2 nMAnanthanarayanan et al.[@CR3]\[DAG\]Diacyl glycerol concentration2000.0 nMMogami et al.[@CR37]tr2aIκB constitutive mRNA synthesis1.54 × 10^−6^ μM s^−1^Hoffmann et al.[@CR25]tr2IκB inducible mRNA synthesis1.65 × 10^−2^μ M^−1^ s^−1^Hoffmann et al.[@CR25]tr3IκB mRNA degradation2.8 × 10^−4^ s^−1^Hoffmann et al.[@CR26]TABLE 4.NFκB rate constants.Rate constantValueSource*k*~5~0.0019 s^−1^Shibasaki et al.[@CR52]*k*~6~0.00092 s^−1^Shibasaki et al.[@CR52]*k*~19~1.0μM^−3^s^−1^Klee et al.[@CR32]; Kakalis et al.[@CR29]*k*~20~1.0 s^−1^Klee et al.[@CR32], Kakalis et al.[@CR29]*k*~21~0.21 s^−1^Estimate and adjusted relative to *k*~22 ~to give equal calcium ion concentrations in nucleus and cytoplasm*k*~22~0.5 s^−1^Estimate*k*~23~0.614 μM^−1^ s^−1^Carlotti et al.[@CR14], Huang et al.[@CR27]*k*~24~0.00184 s^−1^Carlotti et al.[@CR14]*k*~25~0.002 s^−1^Adjusted to control rate of activation/deactivation observed by Dolmetsch et al.[@CR22]*k*~26~1.0 μM^−1^ s^−1^Adjusted to control rate of activation/deactivation observed by Dolmetsch et al.[@CR22]*k*~27~0.00026 s^−1^*k*~2~8/*k*~2~7 = 50; Carlotti et al.[@CR14]*k*~28~0. 0134 s^−1^Estimated from Birbach et al.[@CR12]*k*~29~0.010 s^−1^*k*~3~0/*k*~2~9 = 2, Carlotti et al.[@CR14]*k*~30~0.02 s^−1^Estimate*k*~31~0.000034 s^−1^Estimate*k*~32~0.000034 s^−1^Estimate*k*~33~0.02 s^−1^Estimate*k*~34~0.000034 s^−1^Estimate*k*~35~0.000000036 s^−1^Adjusted to agree with Trushin et al.[@CR56]*k*~36~0.00008 s^−1^Adjusted to agree with Trushin et al.[@CR56]*k*~37~0.0000016 s^−1^Adjusted to agree with Trushin et al.[@CR56]*k*~38~0.0008 s^−1^Adjusted to agree with Trushin et al.[@CR56]*k*~39~0.0016 s^−1^Adjusted to agree with Trushin et al.[@CR56]*k*~40~0.0006 s^−1^Adjusted to agree with Trushin et al.[@CR56]*k*~41~0.02 s^−1^Adjusted to agree with Yang et al.[@CR60]*k*~42~0.000177 s^−1^Adjusted to agree with Yang et al.[@CR60]*k*~43~0.02Estimated from Trushin et al.[@CR56]*k*~44~0.009Estimated from Trushin et al.[@CR56]

NFAT Model {#Sec3}
----------

A schematic diagram of the mechanism for the action of NFAT is shown in Fig. [1](#Fig1){ref-type="fig"}b. A rise in the cytosolic calcium concentration leads to an increased calcium--calmodulin concentration which activates calcineurin (denoted by C\*). Calcineurin binds to and dephosphorylates the cytosolic species NFAT:P~i~, the phosphorylated form of NFAT.[@CR40],[@CR46] Without calmodulin, the phosphatase activity of calcineurin is much reduced.[@CR31] The dephosphorylated NFAT-calcineurin complex (NFAT:C^\*^) translocates to the nucleus, where it may bind to promoter regions of DNA and assist in initiation of gene transcription. A lowering of the calcium concentration results in deactivation of calcineurin and its dissociation from the NFAT-calcineurin complex. Free nuclear NFAT may then be phosphorylated by ubiquitous kinases, masking nuclear localization signals and resulting in translocation from the nucleus to the cytoplasm. Thus rising and falling calcium ion concentrations result in activation and deactivation of the transcription factor NFAT.

There are several simplifying assumptions made in the model for NFAT activation: (1) the total cellular concentration of NFAT remains constant, that is, the degradation and synthesis rates are balanced; (2) dephosphorylated NFAT bound to calcineurin in the nucleus is the transcriptionally active form of NFAT; (3) calcineurin dephosphorylates NFAT in one composite dephosphorylation site (i.e. all sites are treated as one); (4) The cytosolic and nuclear free calcium concentrations are equal and are controlled by a calcium clamp protocol simulating the procedure used by Dolmetsch et al.;[@CR22] (5) calcineurin binds three calcium ions to become active; and (6) NFAT and calcineurin clearly bind to other molecules in the cell, however, these interactions are ignored for simplicity.

A reaction scheme consistent with this mechanism is given in Fig. [2](#Fig2){ref-type="fig"}a. Here nuclear species are shown in the lower half of the figure and given the subscript n. Cytosolic species are shown in the upper half of the figure and given the subscript c. At the low calcium concentrations present in the resting cell the dominant NFAT-containing species is phosphorylated NFAT in the cytoplasm, designated (NFAT:P~i~)~c~ (Fig. [2](#Fig2){ref-type="fig"}a -- dark gray box at left). At the high calcium concentrations present in the activated cell the dominant species is NFAT associated with activated calcineurin in the nucleus, (NFAT:C\*)~n~ (Fig. 2a -- light gray box at right). The model treats cytosolic and nuclear entities as distinct, and thus includes 12 separate chemical species, and cytosolic and nuclear Ca.^2+^. The arrows between species represent forward and reverse chemical reactions, or nuclear import and export. The rates of reaction, and of import and export, are represented by the 22 rate constants, designated *k*~1~ to *k*~22~.

![(a) Reaction scheme for the NFAT mechanism. The activation path for NFAT is shown by the light gray arrows. An increasing calcium concentration activates calcineurin (C), which binds to and dephosphorylates NFAT:P~i~ (dark gray box). The NFAT-activated calcineurin complex NFAT:C\* is imported to the nucleus where it may be transcriptionally active (light gray box). The deactivation path for NFAT is shown by the dark gray arrows. A decreasing calcium concentration allows dissociation of NFAT and activated calcineurin (NFAT:C\*) in the nucleus (light gray box). Free NFAT is phosphorylated and exported to the cytoplasm (dark gray box). (b) Reaction scheme for the NFκB mechanism. The activation path for NFκB is shown by light gray arrows. An increase in the calcium ion concentration activates calcineurin in synergy with PKCα which, through a sequence of reactions, activates an early phase of the kinase IKK. Activation of PKCθ leads to activation of a later phase of IKK. IKK phosphorylates the NFκB:IκB complex (dark gray box) which then dissociates. The phosphorylated IκB is degraded and the free NFκB imported into the nucleus to be the transcriptionally active form (light gray). The deactivation path for NFκB is shown by dark gray arrows. A decrease in the calcium ion concentration allows resynthesis of IκB:P~i~, which enters the nucleus and associates with NFκB. The resulting complex dephosphorylates and is exported from the nucleus.](10439_2006_9179_Fig2_HTML){#Fig2}

Using the law of mass action, this reaction scheme yields a system of 12 coupled first order differential equations describing the change in concentration with time for each of the 12 distinct chemical species (Appendix A). The parameters in the equations include the 22 rate constants and the number of calcium ions required to activate the phosphatase activity of each calcineurin molecule, designated by m in the figure. The time course for the concentrations of each of the chemical species from a given initial condition is determined by numerical solution of the system using a standard fourth order Runge--Kutta technique.

Table [1](#Tab1){ref-type="table"} lists the rate constants used in the NFAT model. They may be loosely divided into three groups: (1) calculated from published data, (2) estimated from published data, and (3) adjusted to fall within expected physiological ranges in order to make the model conform to published experimental data.

NFkB Model {#Sec4}
----------

A schematic diagram of the mechanism of action of NFκB is shown in Fig. [1](#Fig1){ref-type="fig"}b. As previous studies have shown, PKCθ and calcineurin act as co-activators of the transcription factor NFκB.[@CR55],[@CR56] A high calcium concentration activates calcineurin and PKCα, which through a sequence of reactions, co-activates the IKK complex with PKCθ. TCR/CD3 activation leads to the translocation of PKCθ to the immunological synapse (IS), and CD28 activation leads to PKCθ migration to the central supramolecular activation cluster (cSMAC) in the IS.[@CR28] IKK phosphorylates IκB in the complex NFκB:IκB, leading to immediate recognition of IκB by the F-box/WD-domain protein E3RS,^IκB^[@CR61] polyubiquitination of the IκB[@CR20] and subsequent degradation of the IκB by the proteasome. Our model does not explicitly include the polyubiquitination but includes it in the degradation rate of IκB which is essential for NFκB translocation and hence for gene transcription. Once freed of IκB, NFκB translocates to the nucleus where it may bind to DNA and promote gene transcription. When the calcium concentration falls to resting levels, newly synthesized IκB rapidly translocates to the nucleus where it combines with NFκB, masking nuclear localization signals on both species.[@CR6] The NFκB:IκB complex is then exported from the nucleus to the cytoplasm.

There are several simplifying assumptions used to render the model computationally tractable: (1) the total cellular NFκB concentration is constant due to a balance between its synthesis and degradation processes; (2) IκB production is enhanced by activated NFκB as described by Hoffman et al.;[@CR26] (3) the cytosolic and nuclear free calcium concentrations are equal and are controlled by a calcium clamp protocol simulating the procedure used by Dolmetsch et al.;[@CR22] (4) the IKK kinases are lumped into one reaction; (5) in the model IκB represents IκBα; (6) the amount of free NFκB in the nucleus is used as a measure of the activation of the transcription factor; (7) calcineurin binds 3 calcium ions to become active; and (8) the binding of calcineurin, IκB, and NFκB to other molecules in the cell clearly occurs, but is not included in the model for simplicity.

A reaction scheme consistent with this schematic diagram is shown in Fig. [2](#Fig2){ref-type="fig"}b. As in the reaction scheme for NFAT, nuclear species are shown in the lower half of the figure and given the subscript n. Cytosolic species are shown in the upper half of the figure and given the subscript c. In the resting cell, the dominant NFκB containing species is NFκB:IκB in the cytoplasm (Fig. [2](#Fig2){ref-type="fig"}b -- dark gray box at right). In the active cell, the dominant species is NFκB~n~ (Fig. 2b -- light gray box at left). The NFκB model has 17 different chemical species with the nuclear and cytosolic concentrations represented separately. As in the NFAT model, the arrows between species represent forward and reverse chemical reactions, or nuclear import and export. The rates of reaction, and of import and export, are represented by the 26 rate constants, designated *k*~5~ and *k*~6~ and *k*~19~ to *k*~42~. Note that *k*~41~ represents the rate of degradation of IκB and *k*~42~ the rate of its resynthesis.[@CR26] From the NFκB reaction scheme a system of 17 coupled first order differential equations may be written, one for the change in concentration with time of each of the 17 distinct chemical species (Appendix B). Given the initial concentration of each species, numerical integration of the system yields the time course of the concentration for each species.

Results and Discussion {#Sec5}
======================

A number of simulations were performed to duplicate experimental results to validate the model. In all simulations, the parameters listed in Tables [1](#Tab1){ref-type="table"}--[4](#Tab4){ref-type="table"} were used unless stated in the figure legends. The only difference in the simulated results was the calcium clamp protocol used.

NFAT Model Results {#Sec6}
------------------

Using the parameter values in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}, the model was allowed to come to steady state at rest (\[Ca\]~i~ = 0.1μM). The resting state concentrations are shown in Table [5](#Tab5){ref-type="table"}. These concentrations were used as initial values when simulating the evolution of the concentration of each species during a transition from the resting state (\[Ca\]~i~ = 0.1 μM) to the active state (\[Ca\]~i~ = 1.0 μM). The results are shown in Fig. [3](#Fig3){ref-type="fig"}a. The high calcium concentration activates calcineurin, which associates with and dephosphorylates NFAT:P~i~ in the cytoplasm; the concentration of NFAT:P~i~ in the cytoplasm falls rapidly. Only a small amount of NFAT:P~i~:C\* is formed in the cytoplasm when activated calcineurin associates with NFAT:P~i~ because it is rapidly dephosphorylated to NFAT:C\*, which in turn is rapidly translocated to the nucleus where it is transcriptionally active. Note in this figure that the change in concentration of the nuclear species appears large relative to the concentrations of the cytosolic species because the volume of the nucleus is smaller than the volume of the cytoplasm by a factor of about 2.4. The light gray arrows in Fig. [2](#Fig2){ref-type="fig"}a show the NFAT activation pathway on the reaction scheme for NFAT. Calcineurin associates with calcium ion, activating calcineurin. The activated calcineurin associates with phosphorylated NFAT and dephosphorylates it. The NFAT:C\* resulting from this dephosphorylation is rapidly imported to the nucleus where it is transcriptionally active.

![(a) Activation of NFAT from the resting state. (b) Deactivation of NFAT from the active state. The reaction paths (Fig. [2](#Fig2){ref-type="fig"}a) for the activation and deactivation of NFAT are determined by observing the sequence of the formation of the various species in the reaction scheme.](10439_2006_9179_Fig3_HTML){#Fig3}

###### 

NFAT resting steady-state concentrations.

  Species              Concentration (nM)
  -------------------- --------------------
  NFAT~n~              0.5219
  NFAT~c~              0.1101
  C\*~n~               0.0505
  C\*~c~               0.0091
  (NFAT:P~i~)~n~       0.2272
  (NFAT:P~i~)~c~       9.4397
  (NFAT:P~i~:C\*)~n~   0.0025
  (NFAT:P~i~:C\*)~c~   0.0022
  (NFAT:C\*)~n~        0.9477
  (NFAT:C\*)~c~        0.0061
  C~n~                 49.198
  C~c~                 9.7108
  Ca~n~^2+^            100
  Ca~c~^2+^            100

A simulation of the deactivation of the activated state is shown in Fig. [3](#Fig3){ref-type="fig"}b. Here the initial concentrations were those of the activated steady state, and the calcium ion concentration was set to 0.1 μM. Figure [3](#Fig3){ref-type="fig"}b shows that the concentration of the transcriptionally active species (NFAT:C\*)~n~ falls rapidly as NFAT and calcineurin dissociate. Consequently the concentration of NFAT~n~ rises as NFAT is freed by the dissociation, and then falls as it is phosphorylated. The concentration of the phosphorylated species (NFAT:P~i~)~n~ never rises very high because this species is rapidly exported from the nucleus. The dark gray arrows in Fig. [2](#Fig2){ref-type="fig"}a show the NFAT deactivation pathway on the reaction scheme for NFAT. After (NFAT:C\*)~n~ dissociates, free NFAT is phosphorylated and exported from the nucleus.

Dolmetsch et al.[@CR22] suggest that non-linearity in the response of NFAT to calcium ion concentration is important in determining how the activity of NFAT depends on oscillations in the calcium ion concentration. Their experiments show that oscillation frequency is the critical factor in differentiating the response of NFAT and NFκB. Our models for both NFAT and NFκB simulate the effect of calcium ion concentration oscillations on the activation of the transcription factors. One such simulation for NFAT is shown in Fig. [4](#Fig4){ref-type="fig"}a. The initial concentrations of the species were those of the resting state and the oscillation period of the calcium ion concentration was 100 s. The calcium ion concentration was fixed at 1.0 μM during the initial 10 s and 0.1 μM during the final 90 s of each oscillation. Figure [4](#Fig4){ref-type="fig"}a shows that the concentration of the transcriptionally active (NFAT:C\*)~n~ rises rapidly during the high calcium concentration pulse and then decays more slowly during the low calcium concentration portion of the period. The concentration of (NFAT:P~i~)~c~ follows the reverse trend, decreasing rapidly when the calcium ion concentration is high and increasing slowly when the concentration is low. A fraction of the NFAT exists as free NFAT in the nucleus, oscillating between the form NFAT~n~ and (NFAT:C\*)~n~ as calcineurin associates with and dissociates from NFAT. We can easily see that in the absence of constant signaling the concentration of transcriptionally active (NFAT:C\*)~n~ would soon fall to resting state levels. This is shown in Fig. [4](#Fig4){ref-type="fig"}a where at 1500 s the calcium ion concentration is set to 0.1 μM. The concentration of the transcriptionally active (NFAT:C\*)~n~ falls and that of (NFAT:P~i~)~c~ rises, both approaching their resting levels as time increases.

![(a) Activation of NFAT by oscillations in the calcium ion concentration. During each period the calcium concentration was high (1.0 μM) for 10 s and low (0.1**μ**M) for 90 s. At 1500 s the calcium concentration was set to the resting state value (0.1 **μ**M) and the system returned to the resting state. (b) The percent of NFAT in the active state is plotted as a function of calcium ion oscillation period. (c) The percent of NFAT in the active state is plotted as a function of average calcium ion concentration for steady state and oscillating calcium ion concentrations. The percent of NFAT in the active steady state decreases below 0.4 **μ**M when the calcium concentration is constant. The percent of NFAT in the active state persists at a high level to less than 0.2 **μ**M average concentration when the calcium concentration oscillates.](10439_2006_9179_Fig4_HTML){#Fig4}

To study how the degree of NFAT activation varies with oscillation frequency, we simulated calcium concentration oscillations using 10 s intervals of high concentration and varying intervals of low concentration, with the total period ranging from 100 to 1800 s (Fig. [4](#Fig4){ref-type="fig"}b). Because the concentration of the transcriptionally active (NFAT:C\*)~n~ varies throughout the period, a sufficient number of periods was simulated to reach a stable state, then the lowest value of (NFAT:C\*)~n~ during the last period was chosen to calculate the percent of NFAT in the transcriptionally active form. We reasoned here that NFAT involved in shuttling in and out of the active form was not likely to bind to DNA and assist in initiation of transcription, thus the lowest value of the concentration of the active form was justified. In this way the fraction of NFAT in the transcriptionally active form was found as a function of the oscillation period. Figure [4](#Fig4){ref-type="fig"}b shows that the percent of NFAT that is transcriptionally active is almost 60% with a 100 s period, and that this fraction falls to less than 10% with a 900 s period. These results agree qualitatively with the results presented by Dolmetsch et al.,[@CR22] in their Fig. [3](#Fig3){ref-type="fig"}b for the percent of gene expression as a function of oscillation period. Their data shows 50% gene expression with a 100 s oscillation, with the percent expression falling to zero for periods of 400 s or more. The quantitative differences between our simulated results and the experimental observations by Dolmetsch et al.[@CR22] possibly occur because they have determined percent gene expression while we calculate percent of NFAT that is transcriptionally active. There might be additional non-linearity or cooperativity introduced in transcription factor binding to DNA and transcription. For example, as mentioned earlier, Fiering et al.[@CR24] observed that the binding of 3 NFAT molecules to a constructed promoter on a DNA strand produced cooperativity of transcription. They also suggested a similar requirement for NFκB activation of gene expression. While inclusion of these factors would result in a more quantitatively accurate reproduction of the reporter gene expression data, we chose to simplify the model to emphasize the mechanisms for activation of the transcription factors.

Dolmetsch et al.[@CR22] show that the percent of cells expressing a lacZ+ reporter gene, sensitive to transcriptionally active NFAT, decreased when the steady-state calcium concentration fell below about 0.35 μM. But if the calcium concentration exhibited oscillations, the gene expression persisted to an average calcium concentration at least as low as 0.2 μM. The model displays similar behavior (Fig. [4](#Fig4){ref-type="fig"}c). To simulate oscillations, 10 s periods of high calcium concentration and 90 s periods of low calcium concentration were used. The low calcium concentration was fixed at 0.1 μM, and the concentration during the high calcium intervals was fixed in each of several tests to produce a set of experiments each having a different average calcium concentration. Model data for the steady state was obtained following the protocol described previously. Figure [4](#Fig4){ref-type="fig"}c shows that simulating oscillations does indeed enhance the activity of NFAT at low calcium concentrations relative to the activity at a constant calcium concentration. The shape of the curves representing steady state and oscillating calcium concentration behavior are quite similar to those shown by Dolmetsch et al.,[@CR22] in their Fig. [2](#Fig2){ref-type="fig"}c. The two calculated curves meet at a calcium concentration of 0.39 μM, very close to the 0.35 μM shown in the experimental work. This corresponds to a period of approximately 30 s. If the period is longer than 30 s (the average calcium is lower than 0.39 μM), then the oscillations are more potent than steady-state calcium with the same average at activating NFAT. If higher, the opposite is true. The model data shows enhanced NFAT activity down to about 0.2 μM, below which the activity decreases rapidly.

Finally, the NFAT model was tested to determine if it correctly simulates the observation that overexpression of calcineurin partially replaces the requirement for calcium, as reported by Luo et al.[@CR35] These simulations were carried out by holding the calcium ion concentration fixed at the resting state value, 0.1 μM, and varying the calcineurin concentration, followed by calculating the degree of activation of the NFAT. Figure [5](#Fig5){ref-type="fig"} shows the results obtained when the calcineurin concentration was increased as much as a factor of 25 times above the baseline concentration. The percent of NFAT in the transcriptionally active form does indeed increase when the calcineurin concentration increases, and high levels of activation are achieved with high calcineurin concentrations.

![Percent active NFAT as a function of calcineurin concentration at fixed low calcium ion concentration. The calcium concentration was fixed at a level characteristic of the resting state (0.1 **μ**M) and the calcineurin concentration increased to simulate overexpression of calcineurin. Each data point shows the steady state concentration of transcriptionally active NFAT at a fixed calcineurin concentration. Overexpression of calcineurin replaces the requirement for calcium at fixed low calcium concentration.](10439_2006_9179_Fig5_HTML){#Fig5}

NFκB Model Results {#Sec7}
------------------

The NFκB model was characterized in a manner similar to that for the NFAT model. Using the parameters from Tables [2](#Tab2){ref-type="table"}--[4](#Tab4){ref-type="table"}, the calcium concentration was fixed at 0.1 μM and the time evolution of the concentration of each species calculated until steady state values were observed. These concentrations were taken to be those of the steady state at rest (Table [6](#Tab6){ref-type="table"}).TABLE 6.NFκB resting steady-state concentrations.SpeciesConcentration (nM)NFκB~n~7.1779NFκB~c~0.0731(IκB:P~i~)~n~0.2035(IκB:P~i~)~c~0.0525(NFκB:IκB:P~i~)~n~0.2343(NFκB:IκB:P~i~)~c~0.1076(NFκB:IκB)~n~0.2376(NFκB:IκB)~c~52.961C\*~n~0.0505C\*~c~0.0091C~n~49.198C~c~9.7108$\documentclass[12pt]{minimal}
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Figure [6](#Fig6){ref-type="fig"}a shows the concentrations of species in the NFκB model during a transition from the resting to active states. Starting with the resting steady state concentrations, the calcium ion concentration was fixed at 1.0 μM and the time evolution of the concentration of each species calculated. The high calcium concentration activates calcineurin, which in synergy with PKCα and PKCθ, co-activates the kinase IKK. The activated kinase phosphorylates IκB associated with NFκB in the cytoplasm. Subsequent polyubiquitination and IκB degradation result in a decrease in the cytoplasmic NFκB:IκB:P~i~ concentration, a dissociation of NFκB and IκB, and rapid translocation of NFκB into the nucleus. The concentration of cytosolic NFκB never rises very high because of its rapid nuclear import, therefore the concentration of this species is not shown in Fig. [6](#Fig6){ref-type="fig"}a. The light gray arrows in Fig.[2](#Fig2){ref-type="fig"}b show the NFκB activation pathway on the reaction scheme for NFκB. A rise in the calcium concentration activates calcineurin, which through a sequence of reactions, and in synergy with PKCα, activates an early phase of the kinase IKK. CD3/CD28 activate PKCθ, leading to activation of a later phase of IKK.[@CR56] Activated IKK phosphorylates the NFκB:IκB complex in the cytoplasm. After dissociation, the phosphorylated IκB is polyubiquitinated and degraded, and free NFκB is imported to the nucleus where it may be transcriptionally active.

![(a) Activation of NF**κ**B from the resting state. (b) Deactivation of NFκB from the active state. The sequence of events depicted in Fig. [2](#Fig2){ref-type="fig"}b can be determined by observing the time evolution of the concentration of the different reaction species.](10439_2006_9179_Fig6_HTML){#Fig6}

Deactivation of the activated state of NFκB is shown in Fig. [6](#Fig6){ref-type="fig"}b. The initial concentrations were those of the activated state at equilibrium, and the calcium ion concentration was fixed at 0.1 μM. The most important step in deactivation is synthesis of new IκB, which is rapidly translocated to the nucleus forming the phosphorylated complex with NFκB. This complex is dephosphorylated and rapidly translocated into the cytoplasm. The result is an overall increase in concentration of NFκB:IκB in the cytoplasm as the concentration of NFκB in the nucleus decreases. The dark gray arrows in Fig. [2](#Fig2){ref-type="fig"}b show the pathway for deactivation on the reaction scheme for NFκB. Newly synthesized IκB is imported to the nucleus where it associates with NFκB. The resulting complex dephosphorylates, and the NFκB:IκB complex is exported to the cytoplasm. As for NFAT, Dolmetsch et al.,[@CR22] have studied the degree of gene expression caused by NFκB as a function of steady-state calcium ion concentration. In their paper, Fig. [3](#Fig3){ref-type="fig"}a shows that NFAT and NFκB behave in a similar manner; they exhibit a highly non-linear sigmoidal dependence, with very little gene expression at calcium ion concentrations of 0.1 μM or less, a rapid rise in gene expression at calcium concentrations between 0.1 μM and 0.5 μM, and near 100% gene expression at calcium concentrations over 0.5 μM. Since we follow the calcium clamp protocols used by Dolmetsch and co-workers, which does not involve CD3 or CD28 activation and hence does not involve activation of PKCθ, we do not activate PKCθ in these simulations. Figure [7](#Fig7){ref-type="fig"} shows our simulated results for NFκB without PKCθ activation, with the percent of NFκB that is transcriptionally active plotted as a function of the calcium ion concentration. These results were obtained by setting the calcium ion concentration to the desired value, then calculating the concentration of transcriptionally active NFκB as a function of time until a steady state was reached. There is good agreement between our simulated behavior and the experimental results of Dolmetsch et al.[@CR22] Both show activation of NFκB over the physiological range of calcium ion concentrations, with little activity at low concentrations and full activity at high concentrations. The sigmoidal shape of the calculated curve agrees with the experimental results.

![Dependence of the percent active NFκB on the steady-state calcium concentration. For each data point the calcium ion concentration was fixed at the indicated value.](10439_2006_9179_Fig7_HTML){#Fig7}

As was done for the NFAT model, the NFκB model will simulate the system response to calcium oscillations. An example of NFκB activation by calcium concentration oscillations is shown in Fig. [8](#Fig8){ref-type="fig"}a. The initial concentrations were those of the resting steady state and the oscillation period was 100 s. The calcium ion concentration was fixed at 1.0 μM during the initial 10 s of each period and at 0.1 μM for the remaining 90 s of each period. When the calcium concentration is high, the concentration of NFκB:IκB in the cytoplasm falls rapidly, and when the calcium concentration is low the concentration of this species increases slowly. The concentration of NFκB in the nucleus follows the reverse trend, increasing rapidly during the periods of high calcium concentration and falling more slowly when calcium concentration is low.

![(a) Activation of NFκB by oscillations in the calcium ion concentration. During each period the calcium concentration was high (1.0 **μ**M) for 10 s and low (0.1 **μ**M) for 90 s. The concentration of the NF**κ**B:I**κ**B complex in the cytoplasm falls rapidly during periods of high calcium concentration. The concentration of the phosphorylated NF**κ**B:I**κ**B complex first rises, then falls as I**κ**B is degraded. Free NF**κ**B is imported to the nucleus, steadily increasing the concentration of the transcriptionally active nuclear NF**κ**B. (b) Differentiation of the activity of NFAT and NF**κ**B by calcium ion oscillation period. The activity of NF**κ**B decreases as the oscillation period increases (upper curve) but not as much as for NFAT (lower curve); the percent active NF**κ**B is greater than that of NFAT for a given calcium concentration oscillation period. This dissimilarity in behavior differentiates the response of NFAT and NF**κ**B to calcium concentration oscillations.](10439_2006_9179_Fig8_HTML){#Fig8}

During the calcium oscillations, the concentration of the transcriptionally active nuclear NFκB rises, showing little oscillation because of the relatively slow rate of the polyubiquitination and IκB degradation steps. In the absence of constant signaling the concentrations of the species return to their resting levels. In Fig. [8](#Fig8){ref-type="fig"}a the concentration of Ca^2+^ is set to 0.1μM at 2000 s, after which the concentration of nuclear NFκB falls, and that of (NFκB:IκB)~c~ rises, to levels characteristic of the resting state.

We studied how the degree of NFκB activation varied with calcium concentration oscillation period as we did for the NFAT model. Figure [8](#Fig8){ref-type="fig"}b shows the results of simulations with periods varying from 100 to 2000 s. For the shortest period, the percent of active NFκB was 70%, and at the longest period the percent active NFκB was 20%. These results agree qualitatively with those shown by Dolmetsch et al.,[@CR22] in their Fig. [3](#Fig3){ref-type="fig"}b. Their figure shows over 90% gene expression with a 100 s period, falling to less than 20% gene expression for an 1800 s period. Note that they have determined percent gene expression while we calculate percent of transcriptionally active NFκB, a difference that may explain the quantitative difference in the results.

Figure [8](#Fig8){ref-type="fig"}b combines the model results for NFAT and NFκB to compare the effect of oscillation frequency on activation of NFκB to the activation of NFAT by including the curve from Fig. [4](#Fig4){ref-type="fig"}b Figure [8](#Fig8){ref-type="fig"}b shows that a higher fraction of the NFκB is transcriptionally active than that of NFAT for long oscillation periods. These results agree qualitatively with those shown in Dolmetsch et al.,[@CR22] Fig. [3](#Fig3){ref-type="fig"}b, where gene expression by NFAT declined rapidly with oscillation frequency but persisted to long periods for NFκB.

Figure [9](#Fig9){ref-type="fig"}a simulates the results of Yang et al.,[@CR60] who studied the degradation of IκBα with time in fibroblasts. To simulate this, we have used Ca^2+^ oscillations with a period of 100 s and assumed that degradation is the same for all members of the IκB family and then plotted the percent of IκB remaining with time. We have also assumed that the active PKCθ and PKCα concentrations drop after 30 min based on the experimental observations of Szamel et al.[@CR53] who report that PKCθ and PKCα translocated rapidly to the membrane within 1--10 min and start to decline after 30 min. This was simulated with the model by reducing the amounts of active PKCθ and PKCα concentrations to resting values at 40 min (Fig. [9](#Fig9){ref-type="fig"}a). The simulation shows that there is near complete degradation of IκB in about 30 min, which agrees with the experimental results shown in Yang et al.[@CR60] in their Fig. [2](#Fig2){ref-type="fig"}. They observed an increase in IκB concentration after about 40 min.

![(a) Degradation of I**κ**B with time during Ca^2+^ oscillations with period 100 s. Activation of PKCθ and PKCα is terminated at 40 s. (b) Percent active NF**κ**B as a function of the rate of degradation of NF**κ**B. At steady state and at high calcium concentration the percent of active NF**κ**B is sensitive to the rate of I**κ**B degradation assumed in the model. As the degradation rate decreases the percent of active NF**κ**B decreases. Thus the degradation rate must be sufficiently high to obtain significant activation of NF**κ**B. The NF**κ**B model uses a degradation rate of 0.02 s^−1^.](10439_2006_9179_Fig9_HTML){#Fig9}

Figure [9](#Fig9){ref-type="fig"}b shows that the rate of degradation of IκB is an essential factor in the activation of NFκB. Here the dependence of the percent active NFκB is shown as a function of the IκB constitutive degradation rate, *k*~41~ in the NFκB model. Our NFκB model uses a degradation rate of 0.02 s^−1^. As the degradation rate decreases below this value the percent of active NFκB decreases, thus a sufficiently high IκB degradation rate is required for efficient NFκB activation.

Sensitivity Analysis {#Sec8}
====================

To further characterize the system, a sensitivity analysis was performed to determine which steps in the reaction schemes for NFAT and NFκB exerted the most influence on the activation of the transcription factors. To this end, each rate constant was increased and decreased by 10%. The percent change of steady-state active transcription factor at 1.0 μM calcium over the control was calculated (Fig. [10](#Fig10){ref-type="fig"}). The sensitivity was calculated by$$\documentclass[12pt]{minimal}
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![(a) Sensitivity analysis for NFAT activation. (b) Sensitivity analysis for NFκB activation. In both cases, the rate constants were increased and decreased by 10%. The sensitivity of the steady state concentration of active transcription factor at 1.0 μM calcium to changes in the rate constants is shown.](10439_2006_9179_Fig10_HTML){#Fig10}

For NFAT (Fig. [10](#Fig10){ref-type="fig"}a), the rate constants that seem to exert the greatest effect on activation are *k*~9~, *k*~10~, *k*~13~, *k*~14~, *k*~15~, *k*~16,~*k*~19~, and *k*~20~. The rate constants *k*~9~ and *k*~10~ control the rate of nuclear import and export of NFAT and the rate constants *k*~13~ and *k*~14~ control the phosphorylation and dephosphorylation of NFAT by calcineurin. The sensitivities here suggest that increasing the binding affinity of NFAT and calcineurin (*k*~15~ and *k*~16~) will increase activation of NFAT. This is consistent with mutational studies that demonstrate that alteration of the calcineurin binding site on NFAT decreases activation of NFAT.[@CR4],[@CR41] It is interesting to note that even though the sensitivities of NFAT activation to changes in *k*~11~ and *k*~12~ are in the expected directions, the values of these sensitivities are relatively small. Also, increasing the rate of activation of calcineurin through calcium binding (*k*~19~ and *k*~20~) will also increase activation of NFAT. Other rate constants that exert a small but still significant effect are *k*~5~ and *k*~6~ suggesting that an increase in the amount of free cytosolic calcineurin will increase activation of NFAT. This is consistent with Fig. [5](#Fig5){ref-type="fig"} and the experiments that demonstrate that increasing calcineurin increases the activation of NFAT.

For NFκB (Fig. [10](#Fig10){ref-type="fig"}b), the rate constants *k*~30~, *k*~41~, *k*~42~ and tr3 exert the greatest control on the activation of NFκB. The rate constants *k*~23~, *k*~24~, *k*~25~, *k*~26~, *k*~27~, *k*~28~, *k*~43~*k*~44~, tr2 and tr2a also exert a significant influence on activation of NFκB. The rate constants *k*~41~ and *k*~42~ control the degradation and synthesis of IκB. The rate constants tr2, tr2a and tr3 control the rate of IκB mRNA synthesis and degradation. The importance of these rate constants re-emphasizes the importance of the removal of free IκB from the cystosol for activation of NFκB as indicated by Fig. [9](#Fig9){ref-type="fig"}. The rate constants *k*~43~ and *k*~44~ control the shuttling of IKK between the cytoplasm and the nucleus. The rate constants *k*~30~ and *k*~29~ control the import of IκB into the nucleus. Preventing the import of IκB into the nucleus increases the activation of NFκB as it lowers the amount of IκB available to bind NFκB which leads to its export from the nucleus. The rate constants *k*~23~ and *k*~24~ control the dissociation of NFκB and IκB. Increasing the dissociation rate increases activation of NFκB. The effect of the rate constants *k*~25~ and *k*~26~ demonstrate that increasing the rate of phosphorylation of IκB by IKK increases the activation of NFκB. Finally, decreasing *k*~27~, the rate constant for export of NFκB out of the nucleus, or increasing *k*~28~, the rate of import NFκB to the nucleus, increases the amount of activation of NFκB. This effectively increases the amount of NFκB in the nucleus. It is interesting that although reducing the rate of phosphorylation of IKK by calcineurin does inhibit NFkB translocation to the nucleus, this is not one of the most sensitive parameters. The sensitivity analysis suggests that there are several other targets that will block NFAT and NFκB translocation. For several of the targets on NFAT, there is experimental data to support the model predictions about the sensitivities. On the other hand, the prediction that blocking of NFAT translocation decreases transcription has yet to be verified experimentally. This might be accomplished by developing a compound that either binds the nuclear import site of NFAT or that blocks the import mechanism. For NFκB the prediction of this analysis is that the most effective target would be to block IκB degradation or increase its re-synthesis. Another potent target would be to block NFκB translocation. Other possible interventions to block NFκB translocation would be to introduce compounds that increase the affinity of NFκB for IκB or that increase the activity of IKK. These are not the only possible sites as many accessory pathways regulate this system. Future studies that build on this model and explore these pathways will give further insight.

Conclusions {#Sec9}
===========

We have developed models for the calcium and PKCθ mediated activation and deactivation of the transcription factors NFAT and NFκB that incorporate experimentally determined reaction pathways and that simulate this action over physiological calcium concentrations. The model reproduces experimentally observed behaviors of both the NFAT and NFκB systems under a variety of conditions.

Several parameters values for T cells were not available and therefore were derived from experimental observations in cells other than the T cell. For the most part these choices are reasonable estimates, but should be examined further as new data on signaling during T cell activation becomes available. Variations in some estimates will have a greater influence on model outcomes than the others. For example, the total concentration of NFκB was taken from fibroblast data,[@CR13] but this mostly affects the amount activated rather than the percent activated yielding a small control coefficient (0.0127). On the other hand, sensitivity analysis indicates that the degradation rate of IκB that was estimated using data from fibroblasts[@CR60] would exert a greater influence on model results and thus its choice is more critical.

While the model is qualitatively accurate, simulation of the reporter gene levels observed by Dolmetsch and colleagues might be more closely approximated by the inclusion of additional features to the model. Several of these enhancements are obvious and consist of including elements both upstream and downstream of the system modeled. For example, binding of the transcription factors to the DNA might be added along with steps to describe the expression of the reporter genes observed in the experiment. Inclusion of these steps would require adding significant complexity to the model that might obstruct demonstration of the mechanisms governing activation of the calcium dependent transcription factors NFAT and NFκB. Thus, addition of these steps has been left for future work.

Although this model is able to simulate the calcium clamp in the *in vitro* experiments used by Dolmetsch and co-workers, *in vivo* the T cell has more complex calcium dynamics. One aspect of these dynamics is the calcium activation of PKC and its feedback on phospholipase C (PLC). Many studies have indicated that PKC acts as a co-activator of the transcription factors NFAT and NFκB through its effect on calcineurin.[@CR18],[@CR55] According to Pfeifhofer et al.,[@CR42] PKCθ is predominately expressed in T-lymphocytes. They found that PKCθ increases NFAT and NF-κB activation by reducing the intracellular calcium elevation through a reduction in IP~3~ production. They also found that PKCα does this to a lesser degree. The current model includes the activation of PKCθ and its effect on IKK complex. Future work might include any feedback of PKC on PLC and possibly the actions of other PKCs.[@CR47]

Two computational models have been developed by other authors to model the dynamics of NFκB in T-lymphocytes. The model developed by Carlotti et al.,[@CR13] describes the association and dissociation of NFκB and IκB and their translocation into the nucleus both in the associated and dissociated forms. Their model demonstrates that NFκB is localized in the cytoplasm at rest due to its association with IκB and the export of NFκB from the nucleus. A second model, developed by Hoffman and co-workers, demonstrated that the temporal control was due to coordinated degradation and resynthesis of IκB and that IκB provides a strong negative feedback that can turn off the NFκB response.
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\begin{aligned}
\frac{d\hbox{[(NFAT:C)}_{\rm c}]}{dt}& = k_{16}
[\hbox{NFAT}_{\rm c}][\hbox{C}^\ast_{\rm c}]-k_{15}
[(\hbox{NFAT}:\hbox{C})_{\rm c}]+k_{13}[(\hbox{NFAT:P}_{\rm i}:
\hbox{C})_{\rm c}]\\
&\quad-k_{14}[(\hbox{NFAT:C})_{\rm c}]+
k_{10}[(\hbox{NFAT:C})_{\rm n}]\frac{\hbox{v}_{\rm n}}
{\hbox{v}_{\rm c}}-k_{\rm 9}[(\hbox{NFAT:C})_{\rm c}]\\
\end{aligned}
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\frac{d[\hbox{C}_{\rm n}]}{dt} = k_{\rm 5}[\hbox{C}_{\rm c}]
\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}-k_{\rm 6}
[\hbox{C}_{\rm n}]-k_{19}[\hbox{C}_{\rm n}]
[\hbox{Ca}_{\rm n}^{2+}]^{m}
+k_{20}[\hbox{C}^\ast\hbox{n}]
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\frac{{d}[\hbox{C}_{\rm c}]}{dt} = -k_{\rm 5}[\hbox{C}_{\rm c}]
-k_{\rm 6}[\hbox{C}_{\rm n}]\frac{\hbox{v}_{\rm n}}
{\hbox{v}_{\rm c}}\hbox{c}-k_{19}[\hbox{C}_{\rm c}]
[\hbox{Ca}_{\rm c}^{2+}]^{m}+k_{20}[\hbox{C}^\ast_{\rm c}]
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\frac{d[\hbox{NF}\kappa\hbox{B}]_{\rm n}}{dt} = -{k}_{27}\hbox{[NF}\kappa
\hbox{B}_{\rm n}]+{k}_{28}\hbox{[NF}\kappa\hbox{B}_{\rm c}]
\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}
-{k}_{23}\hbox{[NF}\kappa\hbox{B}_{\rm n}][\hbox{I}\kappa
\hbox{B}_{\rm n}]+{k}_{24}[(NF\kappa B:I\kappa B:P_{\rm i})_{\rm n}]
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\frac{d[\hbox{NF}\kappa\hbox{B}]_{\rm c}}{dt} = -{k}_{28}\hbox{[NF}\kappa
\hbox{B}_{\rm c}]+{k}_{27}\hbox{[NF}\kappa
\hbox{B}_{\rm n}]\frac{\hbox{v}_{\rm n}}{\hbox{v}_{\rm c}}
-{k}_{23}\hbox{[NF}\kappa\hbox{B}_{\rm c}][\hbox{I}\kappa
\hbox{B}_{\rm c}]+{k}_{24}[(NF\kappa B:I\kappa B:P_{\rm i})_{\rm c}]
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\frac{d[\hbox{I}\kappa\hbox{B}]_{\rm n}}{dt} = -{k}_{29}\hbox{[I}\kappa
\hbox{B}_{\rm n}]+{k}_{30}\hbox{[I}\kappa
\hbox{B}_{\rm c}]\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}
-{k}_{23}\hbox{[NF}\kappa\hbox{B}_{\rm n}][\hbox{I}\kappa
\hbox{B}_{\rm n}]+{k}_{24}[(NF\kappa B:I\kappa B:P_{\rm i})_{\rm n}]
$$\end{document}$$$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\begin{aligned}
\frac{d[\hbox{I}\kappa\hbox{B}]_{\rm c}}{dt}& = -{k}_{30}[\hbox{I}\kappa
\hbox{B}_{\rm c}]+{k}_{29}[\hbox{I}\kappa
\hbox{B}_{\rm n}]\frac{\hbox{v}_{\rm n}}{\hbox{v}_{\rm c}}
-{k}_{23}[\hbox{NF}\kappa\hbox{B}_{\rm c}][\hbox{I}\kappa
\hbox{B}_{\rm c}]+{k}_{24}\hbox{[(NF}\kappa
\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm c}] \\
&-{k}_{41}[\hbox{I}\kappa
\hbox{B}_{\rm c}]+{k}_{42}[I\kappa B_{t}]\\
\end{aligned}
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\frac{d[\hbox{I}\kappa\hbox{B}]_{\rm t}}{dt} = \hbox{tr2a}+\hbox{tr2}[\hbox{NF}\kappa\hbox{B}_{\rm n}]-\hbox{tr3}[\hbox{I}\kappa\hbox{B}_{\rm t}]
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\begin{aligned}
\frac{d[\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i}]_{\rm n}}{dt}& = {k}_{23}
\hbox{[NF}\kappa \hbox{B}_{\rm n}][\hbox{I}\kappa\hbox{B}_{\rm n}]
-{k}_{24}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm n}]
-{k}_{25}[(\hbox{NF}\kappa \hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm n}]\\
&\quad +k_{32}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm c}]
\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}-k_{31}
[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm n}]\\
\end{aligned}
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\begin{aligned}
\frac{d[\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i}]_{\rm c}}{dt}& = {k}_{23}
\hbox{[\hbox{NF}}\kappa\hbox{B}_{\rm c}][\hbox{I}\kappa\hbox{B}_{\rm c}]
-{k}_{25}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm c}]
+{k}_{26}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B})_{\rm c}][\hbox{IKK}^{\ast}]\\
&\quad-{k}_{24}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm c}]
+{k}_{31}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm n}]
\frac{\hbox{v}_{\rm n}}{\hbox{v}_{\rm c}}-{k}_{32}
[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm c}]\\
\end{aligned}
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\frac{d[\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B}]_{\rm n}}{dt} = {k}_{25} \hbox{[(\hbox{NF}}\kappa\hbox{B:I}\kappa \hbox{B:P}_{\rm i})_{\rm n}]
+{k}_{34}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B})_{\rm c}]
\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}-{k}_{33}
[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B})_{\rm n}]
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\begin{aligned}
\frac{d[\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B}]_{\rm c}}{dt}& = {k}_{25}
\hbox{[(\hbox{NF}}\kappa\hbox{B:I}\kappa\hbox{B:P}_{\rm i})_{\rm c}]
-{k}_{26}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B})_{\rm c}][\hbox{IKK}^\ast]
+{k}_{33}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B})_{\rm n}]\frac{\hbox{v}_{\rm n}}
{\hbox{v}_{\rm c}}\\
&\quad-{k}_{34}[(\hbox{NF}\kappa\hbox{B:I}\kappa\hbox{B})_{\rm c}]\\
\end{aligned}
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\frac{d[\hbox{C}^\ast]_{\rm n}}{dt} = -{k}_{20}[{\hbox{C}^\ast}_{\rm n}]
+{k}_{19}[\hbox{C}_{\rm n}][\hbox{Ca}_{\rm n}^{2+}]^{\rm p}-
{k}_{\rm 6}[{\hbox{C}^\ast}_{\rm n}]+{k}_{\rm 5}
[{\hbox{C}^{\ast}}_{\rm c}]\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}
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\frac{d[\hbox{C}^{\ast}]_{\rm c}}{dt} = -k_{20}[{\hbox{C}^{\ast}}_{\rm c}]+k_{19}
[\hbox{C}_{\rm c}][\hbox{Ca}_{\rm c}^{2+}]^{\rm p}+{k}_{\rm 6}[{\hbox{C}^{\ast}}_{\rm n}]
\frac{\hbox{v}_{\rm n}}{\hbox{v}_{\rm c}}-k_{\rm 5}[{C^{\ast}}_{\rm c}]
$$\end{document}$$$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{d[\hbox{C}]_{\rm n}}{dt} = {k}_{20}[{\hbox{C}^\ast}_{\rm n}]
-{k}_{19}[\hbox{C}_{\rm n}][\hbox{Ca}_{\rm n}^{2+}]^{\rm p}
+{k}_{\rm 5}[\hbox{C}_{\rm c}]
\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}
-{k}_{\rm 6}[\hbox{C}_{\rm n}]
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\frac{d[\hbox{C}]_{\rm c}}{dt} = {k}_{20}[{\hbox{C}^{\ast}}_{\rm c}]-{k}_{19}
[\hbox{C}_{\rm c}][\hbox{Ca}_{\rm c}^{2+} ]^{\rm p}-{k}_{5}
[\hbox{C}_{\rm c}]+{k}_{6}[\hbox{C}_{\rm n}]
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\frac{d{f}_{\rm later IKK^{\ast}}}{{dt}} = {k}_{35}
(1-{f}_{\rm later IKK^{\ast}})[{\hbox{PKC}\theta}^{\ast}]
-{k}_{36}f_{{\rm later IKK}^{\ast}}
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\frac{d{f}_{{\rm early IKK}^{\ast}}}{{dt}} = {k}_{37}
(1-f_{{\rm early IKK}^{\ast}})[\hbox{PKC}\alpha\ast]
-{k}_{38}{f}_{{\rm early IKK}^{\ast}}+{k}_{39}
(1-{f}_{{\rm early IKK}^{\ast}})[{\hbox{C}_{\rm n}}^{\ast}]
-{k}_{40}{f}_{{\rm early IKK}^{\ast}}
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\frac{{df}_{{{\rm IKK}_{\rm c}}^{\ast}}}
{{dt}} = \frac{{df}_{{\rm early IKK}^{\ast}}}
{{dt}}+\frac{{df}_{{\rm later IKK}^{\ast}}}
{{dt}}+{k}_{43}{f}_{{{\rm IKK}_{\rm n}}^{\ast}}
\frac{\hbox{v}_{\rm n}}{\hbox{v}_{\rm c}}-{k}_{44}
{f}_{{{\rm IKK}_{\rm c}}^{\ast}}
$$\end{document}$$$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$
\frac{{df}_{{{\rm IKK}_{\rm n}}^{\ast}}}
{\hbox{dt}} = {k}_{44}{f}_{{{\rm IKK}_{\rm c}}^{\ast}}
\frac{\hbox{v}_{\rm c}}{\hbox{v}_{\rm n}}-{k}_{43}
{f}_{{{\rm IKK}_{\rm n}}^{\ast}}
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[\hbox{PKC}\alpha^{\ast}] = [\hbox{PKC}\alpha]_{\rm total}\times n
\left(\frac{[\hbox{Ca}]^{\rm h}}{[\hbox{Ca}]^{\rm h}+K_{\hbox{Ca}}^{\rm h}}\right)\times
\left(\frac{[\hbox{DAG}]}{[\hbox{DAG}]+K_{\rm DAG}}\right)
$$\end{document}$$

NFAT

:   nuclear factor of activated T cells

NFκB

:   nuclear factor κB

PKC

:   protein kinase C

DAG

:   diacyl glycerol

IκB

:   inhibitor for NFκB

IKK

:   IκB kinase

C

:   calcineurin

IL

:   interleukin

TCR

:   T cell receptor

P~i~

:   phosphate
